Velge Bertrand's Form 4 filing
LifeMD, Inc. (LFMD) · filed Aug 31, 2023
- Accession no.
- 0001362118-23-000053
- Filed
- Aug 31, 2023
- Trade date
- Nov 22, 2022-Aug 31, 2023
- Filing delay
- 282 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market purchases total $501.0K. It was filed 282 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Velge BertrandCIK 0001758339 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 22, 2022 | Common Stock | AGrant or awardAcquired | +10,000 | $0.00F1 | $0 | 926,666 | Indirect | |
| Aug 29, 2023 | Common Stock | PPurchaseAcquired | +32,072 | $3.58F2 | +$114,817.76 | 249,482 | Indirect | |
| Aug 30, 2023 | Common Stock | PPurchaseAcquired | +40,000 | $3.76 | +$150,400 | 289,482 | Indirect | |
| Aug 31, 2023 | Common Stock | PPurchaseAcquired | +60,000 | $3.93F3 | +$235,800 | 349,482 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The grant of restricted shares vested incrementally on December 31, 2022 (50%), March 31, 2023 (25%), and June 16, 2023 (25%).
Referenced by the price of 1 transaction in Table I.
- F2
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.54 to $3.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the numbers of shares purchased at each separate price with the ranges set forth.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.86 to $3.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the numbers of shares purchased at each separate price with the ranges set forth.
Referenced by the price of 1 transaction in Table I.